The levels of CD4+ and CD8+ tumor‐infiltrating lymphocytes, as well as CD8+ T cell effector molecules IFNγ and GZMB, within the TME also dramatically increased in tumor‐bearing mice with dual‐drug therapy treatment (Figure 7E–K). Here, CD8A is linked to neoplasm.